What Promimic does

Promimic is a Sweden-based biomaterials company founded in 2004 and headquartered in Göteborg. It develops proprietary nanotechnology surface modification technology that is applied to medical implants—most notably 3D-printed PEEK devices—to enhance osseointegration, the process by which an implant integrates with surrounding bone tissue, and to accelerate patient healing. The company's core technology is a nanoscale surface treatment rather than a finished implant product; Promimic does not sell implants under its own brand but instead delivers its technology as an embedded input into partner-manufactured devices.

The company's business model is B2B technology licensing to medical device manufacturers. Promimic generates revenue through licensing and royalty arrangements under which OEM partners integrate its surface modification process into their implant manufacturing workflows. Its most prominent disclosed partnership is with Curiteva, an Alabama-based manufacturer specializing in 3D-printed PEEK implants. In May 2025, Promimic expanded this relationship to extend beyond spine into cranial and orthopedic applications, broadening its addressable surgical market.

Promimic's customer base consists of medical device manufacturers producing implants that benefit from enhanced bioactivity and tissue integration. Pricing is not publicly disclosed, and the company maintains a small operational footprint (11–50 employees) led by CEO Magnus Larsson, founder/CTO Per Kjellin, co-founder Martin Andersson, CCO Ulf Brogren, and Marketing & Sales Director Diana Mårdbrink. Capital has historically come from Swedish institutional investors including Chalmers Ventures AB, Almi Invest, and Karolinska, with disclosed funding totaling approximately $8.1M across four rounds between 2011 and 2019.

Name

Promimic

Website

https://promimic.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Short description

Promimic is a Sweden-based biomaterials company developing proprietary nanotechnology surface modifications that accelerate osseointegration in medical implants, licensing the technology B2B to device manufacturers such as Curiteva for spine, cranial, and orthopedic 3D-printed PEEK applications.

Ownership category

akta.pro rank

Product category

Medical Device Surface Modification Technology

NAICS

Research and Development in Nanotechnology (541713)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Coating, Engraving & Allied Services (3470)

akta.pro primary industry

3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ)

akta.pro secondary industries

Medical & Dental 3D Printing Services (patient-specific devices, dental labs) (IMAAADAG), Specialty & Functional Coatings (Anti-microbial/Anti-slip/Insulating) (IMAIAKAM)

Keywords

• Implant surface modification
• Osseointegration nanotechnology
• Biomaterial coatings
• PEEK implant technology
• Medical device licensing

Headquarters

HQ city

Göteborg

HQ country

Sweden

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. Technology Licensing: Promimic licenses its proprietary surface modification nanotechnology to medical device manufacturers for integration into their implant products. Revenue is generated through licensing agreements with partners like Curiteva for applications in spine, cranial, and orthopedic implants.

Go-to-market motion1 record

Distribution channels1 record

Core offering

Promimic develops and licenses proprietary nanotechnology-based surface modifications that are applied to medical implants — particularly 3D-printed PEEK implants — to make them bioactive and accelerate osseointegration and healing. The company sells its surface treatment technology to medical device manufacturers for integration into spine, cranial, and orthopedic implant products under OEM and licensing arrangements.

Product overview

Promimic is a Swedish nanotechnology firm that provides surface modification technology for medical implants. The company offers surface enhancement solutions that promote osseointegration and accelerate healing in 3D-printed PEEK implants for spine, cranial, and orthopedic applications. The specific product names and detailed portfolio could not be extracted as the company website was not accessible during data collection.

Differentiator

Problem solved

Functional benefit

Products and services

• Nano Surface Modification Technology for Medical Implants

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• CuritevacoreStrategic or Co-development Partner · 6 May 2025Curiteva, an Alabama-based company specializing in 3D-printed PEEK implants, has expanded its partnership with Promimic to incorporate Promimic's surface modification nanotechnology into its implant technology. The collaboration aims to produce advanced, bioactive implants that promote osseointegration and accelerate healing. The partnership extends their technology application beyond spine to cranial and orthopedic solutions.

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• SurModics: SurModics is a U.S.-listed medical device surface modification company offering proprietary coatings (hydrophilic, hemocompatible, drug-eluting) used in vascular, ophthalmic, and other implantable devices. It is comparable to Promimic as a B2B licensor of surface-modification technologies to medical device OEMs, though it operates at much larger scale and across a broader device portfolio.
• N2 Biomedical: N2 Biomedical offers ion beam and sputter coating services (e.g., titanium niobium nitride, silver, and other thin-film coatings) for orthopedic, spinal, and other medical implants. It is comparable to Promimic as a provider of advanced surface modification coatings used on implantable medical devices.

Direct peers

• Biocoat: Biocoat develops hydrophilic and bioactive coatings for medical devices, including catheter, guidewire, and ophthalmic applications, and licenses its coating technology to OEMs. It is comparable to Promimic because it operates a similar B2B licensing model for surface modification chemistry targeted at medical implants and devices.
• Hydromer: Hydromer manufactures and licenses hydrophilic polymer coatings applied to catheters, guidewires, and other medical devices. It is comparable to Promimic as a coatings licensor supplying surface-modification technology to medical device OEMs under similar licensing economics.
• DOT GmbH: DOT GmbH provides biocompatible coating solutions, including diamond-like carbon and functional coatings, used on orthopedic and dental implants and instruments. It is comparable to Promimic because it supplies surface-enhancement coatings specifically engineered to improve osseointegration and biocompatibility of implants.
• CAM Bioceramics: CAM Bioceramics develops hydroxyapatite and other calcium phosphate coatings used on orthopedic and dental implants to improve bone integration. It is comparable to Promimic because both provide bioactive surface technologies designed to accelerate osseointegration on implantable devices.
• Covalon Technologies: Covalon Technologies develops antimicrobial and biocompatible coatings applied to medical devices and wound care products, licensing its surface technologies to medical device manufacturers. It is comparable to Promimic as a medical surface-coating licensor targeting implant and device OEMs.
• Vesta (SiO2 Medical Products): Vesta (formerly SiO2 Medical Products) provides precision surface treatments and coatings for medical device components, including implants and drug-delivery devices. It is comparable to Promimic as a specialty surface-engineering supplier serving medical implant and device OEMs.

Others

• Innovasis: Innovasis designs and manufactures PEEK-based spinal implant systems and is itself an OEM customer for surface-modification technologies. It is comparable to Promimic's downstream counterparties (e.g., Curiteva) as a 3D-printed and machined PEEK implant manufacturer that could be a candidate adopter of Promimic's technology.
• Orchid Orthopedic Solutions: Orchid Orthopedic Solutions is a contract manufacturer of orthopedic implants and instruments, including coated and surface-treated devices. It is comparable to Promimic as an adjacent participant in the orthopedic implant supply chain that applies or sources surface enhancements for implants.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds4 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Promimic